{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:46:06Z","timestamp":1771328766884,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T00:00:00Z","timestamp":1396483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To compare overall and cancer\u2010specific outcomes between patients with upper tract urothelial carcinoma (\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            ) managed with either radical nephroureterectomy (\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            ) or nephron\u2010sparing measures (\n                            <jats:styled-content style=\"fixed-case\">NSM<\/jats:styled-content>\n                            ) using a large population\u2010based dataset.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Using Surveillance, Epidemiology, and End Results (\n                            <jats:styled-content style=\"fixed-case\">SEER<\/jats:styled-content>\n                            ) data, patients diagnosed with low\u2010 or moderate\u2010grade, localised non\u2010invasive\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            were stratified into two groups: those treated with\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            or\n                            <jats:styled-content style=\"fixed-case\">NSM<\/jats:styled-content>\n                            (observation, endoscopic ablation, or segmental ureterectomy).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Cancer\u2010specific mortality (\n                            <jats:styled-content style=\"fixed-case\">CSM<\/jats:styled-content>\n                            ) and other\u2010cause mortality (\n                            <jats:styled-content style=\"fixed-case\">OCM<\/jats:styled-content>\n                            ) rates were determined using cumulative incidence estimators. Adjusting for clinical and pathological characteristics, the associations between surgical type, all\u2010cause mortality and\n                            <jats:styled-content style=\"fixed-case\">CSM<\/jats:styled-content>\n                            were tested using Cox regressions and Fine and Gray regressions, respectively.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Of 1227 patients [mean (\n                            <jats:sc>sd)<\/jats:sc>\n                            age 70.2 (11.00) years, 63.2% male] meeting inclusion criteria, 907 (73.9%) and 320 (26.1%) patients underwent\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            and\n                            <jats:styled-content style=\"fixed-case\">NSM<\/jats:styled-content>\n                            for low\u2010 or moderate\u2010grade, low\u2010stage\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            from 1992 to 2008.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Patients undergoing\n                            <jats:styled-content style=\"fixed-case\">NSM<\/jats:styled-content>\n                            were older (mean age 71.6 vs 69.7 years,\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.01) with a greater proportion of well\u2010differentiated tumours (26.3% vs 18.0%,\n                            <jats:italic>P<\/jats:italic>\n                            = 0.001).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            While there were differences in\n                            <jats:styled-content style=\"fixed-case\">OCM<\/jats:styled-content>\n                            between the groups (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.01),\n                            <jats:styled-content style=\"fixed-case\">CSM<\/jats:styled-content>\n                            trends were equivalent. After adjustment,\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            treatment was associated with improved non\u2010cancer cause survival [hazard ratio (\n                            <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                            ) 0.78, confidence interval [\n                            <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                            ] 0.64\u20130.94) while no association with\n                            <jats:styled-content style=\"fixed-case\">CSM<\/jats:styled-content>\n                            was demonstrable (\n                            <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                            0.89,\n                            <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                            0.63\u20131.26).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Patients with low\u2010 or moderate\u2010grade, low\u2010stage\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            managed through\n                            <jats:styled-content style=\"fixed-case\">NSM<\/jats:styled-content>\n                            are older and are more likely to die of other causes, but they have similar\n                            <jats:styled-content style=\"fixed-case\">CSM<\/jats:styled-content>\n                            rates to those patients managed with\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            These data may be useful when counselling patients with\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            with significant competing comorbidities.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.12341","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T10:10:25Z","timestamp":1372759825000},"page":"216-220","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Nephron\u2010sparing management vs radical nephroureterectomy for low\u2010 or moderate\u2010grade, low\u2010stage upper tract urothelial carcinoma"],"prefix":"10.1111","volume":"114","author":[{"given":"Jay","family":"Simhan","sequence":"first","affiliation":[{"name":"Division of Urologic Oncology Departments of Surgical Oncology  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C.","family":"Smaldone","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology Departments of Surgical Oncology  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Egleston","sequence":"additional","affiliation":[{"name":"Biostatistics Fox Chase Cancer Center Temple University School of Medicine  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Canter","sequence":"additional","affiliation":[{"name":"Department of Urology Emory University School of Medicine  Atlanta GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven N.","family":"Sterious","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology Departments of Surgical Oncology  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T.","family":"Corcoran","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology Departments of Surgical Oncology  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Ginzburg","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology Departments of Surgical Oncology  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Uzzo","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology Departments of Surgical Oncology  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kutikov","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology Departments of Surgical Oncology  Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20138"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpuro0875"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.12.042"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24135"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70803-8"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01501-7"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24035"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.005"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07535.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.12.034"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.02.038"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64041-4"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67135-2"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2011.0426"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.11.021"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181aec42a"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.09.150"},{"key":"e_1_2_7_19_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program. Research Cancer Data (1973\u20132007) National Cancer Institute DCCPS Surveillance Research Program Cancer Statistics Branch released April 2010 based on the November 2009 submission. Available at:http:\/\/www.seer.cancer.govAccessed 1 March 2013"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.04.020"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.12.018"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/089277901300189439"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01109-8"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00295-7"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.07.004"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.029"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25043"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11691"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.07.099"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.12.014"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.12341","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.12341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:13:16Z","timestamp":1761750796000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.12341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1111\/bju.12341"],"URL":"https:\/\/doi.org\/10.1111\/bju.12341","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]},"assertion":[{"value":"2014-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}